Targeting B-Raf as a treatment strategy for polycystic kidney disease

被引：1
|
作者：
Sas, Kelli M. [1 ]
机构：
[1] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA
来源：
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY | 2010年 / 299卷 / 05期
关键词：
KINASE; PROGRESSION; DISCOVERY; MODEL;
D O I：
10.1152/ajprenal.00485.2010
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页码：F942 / F943
页数：2
相关论文
共 50 条
  • [21] B-RAF基因和肿瘤
    付浩
    孙开来
    国际遗传学杂志, 2007, (03) : 198 - 201
  • [22] Cures with B-Raf inhibitors as single agents in metastatic B-Raf mutated melanoma: Curb your enthusiasm?
    Dasanu, Constantin A.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (01) : 205 - 206
  • [23] Erratum, The role of B-RAF in melanoma
    Vanessa C. Gray-Schopfer
    Silvy da Rocha Dias
    Richard Marais
    Cancer and Metastasis Reviews, 2005, 24 : 367 - 367
  • [24] The roles of B-RAF and C-RAF in human cancer
    不详
    EJC SUPPLEMENTS, 2005, 3 (04): : 10 - 10
  • [25] B-RAF unlocks axon regeneration
    Cavalli, Valeria
    Holtzman, David
    JOURNAL OF EXPERIMENTAL MEDICINE, 2014, 211 (05): : 746 - 746
  • [26] Regulation and role of Raf-1/B-Raf heterodimerization
    Rushworth, LK
    Hindley, AD
    O'Neill, E
    Kolch, W
    MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (06) : 2262 - 2272
  • [27] Raf proteins and cancer: B-Raf is identified as a mutational target
    Mercer, KE
    Pritchard, CA
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2003, 1653 (01): : 25 - 40
  • [28] Targeting Metabolic Reprogramming in Polycystic Kidney Disease
    Boletta, Alessandra
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (12): : 1768 - 1770
  • [29] The synthesis of a novel inhibitor of B-Raf kinase
    Denni-Dischert, D
    Marterer, W
    Bänziger, M
    Yusuff, N
    Batt, D
    Ramsey, T
    Geng, P
    Michael, W
    Wang, RMB
    Taplin, F
    Versace, R
    Cesarz, D
    Perez, LB
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2006, 10 (01) : 70 - 77
  • [30] Guilty as charged: B-RAF is a human oncogene
    Garnett, MJ
    Marais, R
    CANCER CELL, 2004, 6 (04) : 313 - 319
12345